ATYR Pharma target price cut to $6 from $40 after 1-for-40 reverse stock split
ATYR•RBC adjusted its target price for ATYR Pharma to $6 from $40 to reflect a 1-for-40 reverse stock split.
Related News
Sun Life Financial Inc: CIBC cuts target price to C$113 from C$116
SLF•
Gildan Activewear: TD Cowen cuts target price to $49 from $54
GIL•
Ducommun Incorporated: RBC cuts target price to $155 from $180
DCO•
Markets fret over growth and inflation despite easing oil prices
SPY•
Air Products: RBC raises target price to $359 from $346
APD•